A novel coagulation assay incorporating adherent endothelial cells in thromboelastometry

Summary

Following vascular injury or activation, endothelial cells (ECs) participate in the modulation of haemostasis and fibrinolysis. Viscoelastic tests (VETs) are a potent bedside monitoring tool that reports haemostatic parameters in real time. However, VETs neglect the influence of the surrounding endothelium. Our aim was therefore to establish an assay that incorporates ECs in a whole blood VET and to assess the impact of ECs on coagulation parameters. Outgrowth endothelial cells (OECs) and human umbilical vein endothelial cells (HUVECs) were seeded onto microbeads to create transferable EC-microcarriers. Microbeads were then added to citrated whole blood in the measurement cup of a thromboelastometry device (ROTEM). After the addition of CaCl₂ (star-TEM^®) to the blood sample (NATEM assay), standard ROTEM parameters were analysed. Scanning electron microscopy (SEM) was carried out to visualise the interactions of the beads, whole blood components and the ROTEM pin after clotting. SEM showed that the added microbeads were effectively incorporated into the final blood clot. In the presence of activated ECs, the clotting time (CT) of the blood was shortened fourfold compared to that in uncoated control beads. A significant reduction in CT was also observed in the presence of unstimulated ECs. Interestingly, CT was also reduced by the addition of purified EC culture supernatant. CT shortening was prevented by incubating the supernatant with an inhibiting antibody against tissue factor (TF). Our findings demonstrate that ECs can be incorporated into a ROTEM assay via coated microbeads, and whole blood clotting initiation is accelerated by non-activated and activated ECs.

Keywords

Endothelial cells - viscoelastic tests - thromboelastometry - tissue factor

• References

• 1 Hoffman M, Monroe MD. A cell-based Model of Hemostasis. Thromb Haemost 2001; 85: 958-965.
• 2 Riddel JP, Aouizerat BE, Miaskowski C. et al. Theories of blood coagulation. J Ped Oncol Nurs 2007; 24: 123-131.
• 3 Löwenberg EC, Meijers JC, Levi M. Platelet-vessel wall interaction in health and disease. Neth J Med 2010; 68: 242-251.
• 4 Holcomb JB, Minei KM, Scerbo ML. et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg 2012; 256: 476-486.
• 5 Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 2008; 106: 1366-1375.
• 6 Schöchl H, Nienaber U, Hofer G. et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010; 14: R55.
• 7 Fuchs S, Motta A, Migliaresi C. et al. Outgrowth endothelial cells isolated and expanded from human peripheral blood progenitor cells as a potential source of autologous cells for endothelialization of silk fibroin biomaterials. Biomaterials 2006; 27: 5399-5408.
• 8 Holnthoner W, Hohenegger K, Husa AM. et al. Adipose-derived stem cells induce vascular tube formation of Outgrowth Endothelial Cells in a fibrin matrix. J Term. 2012 epub ahead of print
• 9 Nielsen VG, Audu P, Cankovic L. et al. Qualitative Thrombelastographic Detection of Tissue Factor in Human Plasma. Anaesth Analg 2007; 104: 59-64.
• 10 Aird WC. Endothelial Cell Heterogeneity. Cold Spring Harb Perspect Med 2012; 02: a006429.
• 11 van Hinsbergh VW. Endothelium- role in regulation of coagulation and inflammation. Semin Immunopathol 2012; 34: 93-106.
• 12 Nakatsu MN, Sainson RC, Aoto JN. et al. Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. Microvasc Res 2003; 66: 102-112.
• 13 Aird WC. Phenotypic heterogeneity of the endothelium: 1. Structure, function and mechanisms. Circ Res 2007; 100: 158-173.
• 14 Sorensen B, Fenger-Eriksen C, Christiansen K. et al. Evaluation of coagulation kinetics using thromboelastometry—methodologic influence of activator and test medium. Ann Hematol 2010; 89: 1155-1161.
• 15 Zacharowski K, Sucker C, Zacharowski P. et al. Thrombelastography for the monitoring of lipopolysaccharide induced activation of coagulation. Thromb Haemost 2006; 95: 557-561.
• 16 Archipoff G, Beretz A, Freyssinet JM. et al. Heterogeneous regulation of constitutive thrombomodulin or inducible tissue-factor activities on the surface of human saphenous-vein endothelial cells in culture following stimulation by interleukin-1, tumour necrosis factor, thrombin or phorbol ester. Biochem J 1991; 273: 679-684.
• 17 Mazzolai L, Bouzourene K, Hayoz D. et al. Characterization of human late outgrowth endothelial progenitor-derived cells under various flow conditions. J Vasc Res 2011; 48: 443-451.
• 18 Tatsumi K, Ohashi K, Matsubara Y. et al. Tissue factor triggers procoagulation in transplanted mesenchymal stem cells leading to thromboembolism. Biochem Biophys Res Commun. 2013 epub ahead of print
• 19 Scarpati EM, Sadler JE. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem 1989; 264: 20705-20713.
• 20 Ettelaie C, Fountain D, Collier ME. et al. Low molecular weight heparin down-regulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB. Biochim Biophys Acta 2011; 1812: 1591-1600.
• 21 Shen BQ, Lee DY, Cortopassi KM. et al. Vascular Endothelial Growth Factor KDR Receptor Signaling Potentiates Tumor Necrosis Factor-induced Tissue Factor Expression in Endothelial Cells. J Biol Chem 2001; 276: 5281-5286.
• 22 Song HB, Park KD, Kim JH. et al. Tissue factor regulates tumor angiogenesis of retinoblastoma via the extracellular signal-regulated kinase pathway. Oncol Rep 2012; 28: 2057-2062.
• 23 Potter DR, Damiano ER. The Hydrodynamically Relevant Endothelial Cell Glycocalyx Observed In Vivo Is Absent In Vitro. Circ Res 2008; 102: 770-776.
• 24 Schöchl H, Solomon C, Schultz A. et al. Thromboelastometry (TEM®) Findings in Disseminated Intravascular Coagulation in a Pig Model of Endotoxinemia. Mol Med 2011; 17: 266-272.
• 25 Kaneko T, Wada H. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation. J Clin Exp Hematop 2011; 51: 67-76.
• 26 Granger DN, Senchenkova E. Inflammation and the Microcirculation. 2010. San Rafael: Morgan & Claypool Life Sciences;
• 27 Szotowski B, Antoniak S, Poller W. et al. Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines. Circ Res 2005; 96: 1233-1239.
• 28 Li ZM, Delaney K, O’Brien KA. et al. Signaling During Platelet Adhesion and Activation. Arterioscler Thromb Vasc Biol 2010; 30: 2341-2349.
• 29 Shankarraman V, Davis-Gorman G, Copeland JG. et al. Standardized methods to quantify thrombogenicity of blood-contacting materials via thromboelastography. J Biomed Mater Res Part B 2012; 100B: 230-238.
• 30 Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10: 45-65.
• 31 Dignat-George F, Freyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets 2009; 20: 225-226.